top
Search terms
Results 1 - 4 of 4 - ordered by :
Ehjournal

Aims The globalization of clinical trials has highlighted geographic variations in patient characteristics, event rates, and treatment effects. Notable differences included: WE patients (mean age 68 ...

European Heart Journal, Kristensen, Søren Lund, Martinez, Felipe, Jhund, Pardeep S., Arango, Juan Luis, Bĕlohlávek, Jan, Boytsov, Sergey, Cabrera, Walter, Gomez, Efrain, Hagège, Albert ...

Date : 01/11/2016 Item size : 314421 bytes
Ehjournal

Aims The globalization of clinical trials has highlighted geographic variations in patient characteristics, event rates, and treatment effects. Notable differences included: WE patients (mean age 68 ...

European Heart Journal, Kristensen, Søren Lund, Martinez, Felipe, Jhund, Pardeep S., Arango, Juan Luis, Bĕlohlávek, Jan, Boytsov, Sergey, Cabrera, Walter, Gomez, Efrain, Hagège, Albert ...

Date : 01/11/2016 Item size : 343831 bytes
Ejhf

Aims The combined neprilysin/renin–angiotensin system (RAS) inhibitor sacubitril/valsartan reduced cardiovascular death or heart failure hospitalization, cardiovascular death, and all-cause ...

European Journal of Heart Failure, Solomon, Scott D., Claggett, Brian, McMurray, John J.V., Hernandez, Adrian F., Fonarow, Gregg C.

Date : 01/10/2016 Item size : 46771 bytes
Ejhf

Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease [5] In the Trial to Reduce Cardiovascular Events With Aranesp Therapy ...

European Journal of Heart Failure, Bello, Natalie A., Lewis, Eldrin F., Desai, Akshay S., Anand, Inder S., Krum, Henry, McMurray, John J.V., Olson, Kurt, Solomon, Scott D., Swedberg, Karl, van ...

Date : 01/11/2015 Item size : 151336 bytes